Matthieu Pichelin

3.6k total citations · 1 hit paper
30 papers, 1.6k citations indexed

About

Matthieu Pichelin is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Matthieu Pichelin has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Genetics. Recurrent topics in Matthieu Pichelin's work include Lipoproteins and Cardiovascular Health (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Matthieu Pichelin is often cited by papers focused on Lipoproteins and Cardiovascular Health (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Matthieu Pichelin collaborates with scholars based in France, Réunion and Canada. Matthieu Pichelin's co-authors include Murielle Cazaubiel, Jean‐François Bisson, Amine Nejdi, Catherine Rougeot, Robert Lalonde, Didier Desor, Hervé Javelot, Nicolas Violle, Michaël Messaoudi and Bertrand Cariou and has published in prestigious journals such as Gastroenterology, PLoS ONE and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Matthieu Pichelin

30 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticusR0052 andBifidobacterium longumR0175) in rats and human subjects

2010 1.0k citations Michaël Messaoudi, Robert Lalonde et al. British Journal Of Nutrition profile →

Peers

Countries citing papers authored by Matthieu Pichelin

Since Specialization

Citations

This map shows the geographic impact of Matthieu Pichelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Pichelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Pichelin more than expected).

Fields of papers citing papers by Matthieu Pichelin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthieu Pichelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Pichelin. The network helps show where Matthieu Pichelin may publish in the future.

Co-authorship network of co-authors of Matthieu Pichelin

This figure shows the co-authorship network connecting the top 25 collaborators of Matthieu Pichelin. A scholar is included among the top collaborators of Matthieu Pichelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthieu Pichelin. Matthieu Pichelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study 2021 ·Diabetes Research and Clinical Practice ·Bertrand Cariou, Matthieu Pichelin, Thomas Goronflot, (unknown), Michel Marre, (unknown), Charles Thivolet, Matthieu Wargny, Samy Hadjadj, Pierre Gourdy	16
2	PCSK9 regulates the NODAL signaling pathway and cellular proliferation in hiPSCs 2021 ·Stem Cell Reports ·(unknown), (unknown), Amandine Caillaud, (unknown), Antoine Rimbert, Benoite Champon, Amandine David, (unknown), (unknown), Matthieu Pichelin, Xavier Prieur, Annik Prat, Nabil G. Seidah, Kazem Zibara, Cédric Le May, Bertrand Cariou, Karim Si‐Tayeb	12
3	Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with Diabetes and COVID-19: The DIABCOVID Study 2020 ·Journal of Clinical Medicine ·Adèle Lasbleiz, Bertrand Cariou, Patrice Darmon, (unknown), Patricia Ancel, Sandrine Boullu, (unknown), Fanny Romain, Jean‐Christophe Lagier, Mohamed Boucékine, Noémie Resseguier, Pierre Gourdy, Matthieu Pichelin, Matthieu Wargny, Anne Dutour, Bénédicte Gaborit	12
4	Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study 2020 ·Diabetes & Metabolism ·Bertrand Cariou, Thomas Goronflot, Antoine Rimbert, Sandrine Boullu, Cédric Le May, Philippe Moulin, Matthieu Pichelin, Louis Potier, Sarra Smati, Ariane Sultan, Blandine Tramunt, Matthieu Wargny, Pierre Gourdy, Samy Hadjadj	60
5	Routine use of statins and increased mortality related to COVID-19 in inpatients with type 2 diabetes: Results from the CORONADO study. 2020 ·Diabetes & Metabolism ·Bertrand Cariou, Thomas Goronflot, Antoine Rimbert, Sandrine Boullu, Cédric Le May, Philippe Moulin, Matthieu Pichelin, Louis Potier, Sarra Smati, Ariane Sultan, Blandine Tramunt, Matthieu Wargny, Pierre Gourdy, Samy Hadjadj	10
6	Roux-en-Y gastric bypass, but not sleeve gastrectomy, decreases plasma PCSK9 levels in morbidly obese patients 2020 ·Diabetes & Metabolism ·Claire Blanchard, Séverine Ledoux, Ann Verhaegen, Matthieu Wargny, E Letessier, Alain Stépanian, N. Huten, David Jacobi, Michel Krempf, M. Le Bras, (unknown), (unknown), Matthieu Pichelin, L. Van Gaal, Bertrand Cariou, Cédric Le May	5
7	Improvement in arterial stiffness (pOpmètre®) after bariatric surgery. Results from a prospective study 2020 ·Annales d Endocrinologie ·(unknown), David Jacobi, Matthieu Pichelin, Bertrand Cariou, Éric Mirallié, Claire Blanchard	8
8	Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes 2019 ·Atherosclerosis ·Stéphane Ramin‐Mangata, Matthieu Wargny, Matthieu Pichelin, Cédric Le May, Aurélie Thedrez, Valentin Blanchard, Brice Nativel, Raúl D. Santos, Isabela M Benseñor, Paulo A. Lotufo, Gilles Lambert, Bertrand Cariou	17
9	No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study 2019 ·Journal of Diabetes and its Complications ·Pierre‐Jean Saulnier, Claire Briet, Elise Gand, Lucy Chaillous, Séverine Dubois, Fabrice Bonnet, (unknown), G. Fradet, (unknown), V. Kerlan, D. Gouet, C. Perlemoine, Pierre Henri Ducluzeau, Matthieu Pichelin, Matthieu Wargny, Linda Gonder‐Frederick, Stéphanie Ragot, Samy Hadjadj, Bertrand Cariou	8
10	Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes 2019 ·Metabolism ·Oscar Chávez‐Talavera, Matthieu Wargny, Matthieu Pichelin, Amandine Descat, Emmanuelle Vallez, Mostafa Kouach, Edith Bigot‐Corbel, (unknown), Jean‐François Goossens, Cédric Le May, Samy Hadjadj, Rémy Hanf, Anne Tailleux, Bart Staels, Bertrand Cariou	33
11	Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study 2019 ·PLoS ONE ·Matthieu Wargny, Sarra Smati, Matthieu Pichelin, Edith Bigot‐Corbel, (unknown), (unknown), Yassine Zaïr, (unknown), Samy Hadjadj, Jérôme Boursier, Bertrand Cariou	31
12	Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population 2018 ·Atherosclerosis ·Matthieu Wargny, Pierre‐Henri Ducluzeau, Jean‐Michel Petit, Cédric Le May, Sarra Smati, (unknown), Matthieu Pichelin, Benjamin Bouillet, Adrien Lannes, Odile Blanchet, Philippe Lefèbvre, Sven Francque, Luc Van Gaal, Bart Staels, Bruno Vergès, Jérôme Boursier, Bertrand Cariou	32
13	Prevalence of hypobetalipoproteinemia and related psychiatric characteristics in a psychiatric population: results from the retrospective HYPOPSY Study 2018 ·Lipids in Health and Disease ·Bertrand Cariou, Gaëlle Challet‐Bouju, (unknown), (unknown), Jean-Benoît Hardouin, (unknown), Kalyane Bach‐Ngohou, Christophe Leux, Matthieu Pichelin, Marie Grall‐Bronnec	10
14	Association Between Hypoglycemia and the Burden of Comorbidities in Hospitalized Vulnerable Older Diabetic Patients: A Cross-Sectional, Population-Based Study 2017 ·Diabetes Therapy ·Laure de Decker, Olivier Hanon, Anne‐Sophie Boureau, Guillaume Chapelet, (unknown), Matthieu Pichelin, Gilles Berrut, Bertrand Cariou	21
15	Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor) 2017 ·Arteriosclerosis Thrombosis and Vascular Biology ·Aurélie Thedrez, Dirk Blom, Stéphane Ramin‐Mangata, Valentin Blanchard, Mikaël Croyal, Kévin Chemello, Brice Nativel, Matthieu Pichelin, Bertrand Cariou, Steeve Bourane, Lihua Tang, Michel Farnier, Frederick J. Raal, Gilles Lambert	74
16	Plasma PCSK9 concentrations during the course of nondiabetic chronic kidney disease: Relationship with glomerular filtration rate and lipid metabolism 2016 ·Journal of clinical lipidology ·Marion Moréna, Cédric Le May, Leïla Chénine, (unknown), Anne‐Marie Dupuy, Matthieu Pichelin, Hélène Leray‐Moragues, Lotfi Chalabi, Bernard Canaud, Jean‐Paul Cristol, Bertrand Cariou	28
17	Identification of novel APOB mutations by targeted next-generation sequencing for the molecular diagnosis of familial hypobetalipoproteinemia 2016 ·Atherosclerosis ·Antoine Rimbert, Matthieu Pichelin, Simon Lecointe, (unknown), Solena Le Scouarnec, (unknown), Mikaël Croyal, Michel Krempf, Hervé Le Marec, Richard Redon, Jean‐Jacques Schott, Jocelyne Magré, Bertrand Cariou	15
18	Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia 2015 ·Disease Models & Mechanisms ·Karim Si‐Tayeb, (unknown), Benoite Champon, Amandine Caillaud, Matthieu Pichelin, (unknown), Patricia Lemarchand, Cédric Le May, Kazem Zibara, Bertrand Cariou	42
19	Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticusR0052 andBifidobacterium longumR0175) in rats and human subjects breakdown → 2010 ·British Journal Of Nutrition ·Michaël Messaoudi, Robert Lalonde, Nicolas Violle, Hervé Javelot, Didier Desor, Amine Nejdi, Jean‐François Bisson, Catherine Rougeot, Matthieu Pichelin, Murielle Cazaubiel, (unknown)	1013
20	Short-term digestive tolerance of chocolate formulated with maltitol in children 2010 ·International Journal of Food Sciences and Nutrition ·Clémentine Thabuis, Murielle Cazaubiel, Matthieu Pichelin, Daniel Wils, Laetitia Guérin‐Deremaux	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact